RETRACTED ARTICLE: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism

Nazila Fathi Maroufi, Vahid Vahedian, Seyed Ali Miresmaeili Mazrakhondi, Wesam Kooti, Hosein Ajami Khiavy, Roya Bazzaz, Fatemeh Ramezani, Seyed Mohammadbagher Pirouzpanah, Marjan Ghorbani, Maryam Akbarzadeh, Hamed Hajipour, Saeed Ghanbarzadeh, Mehdi Sabzichi

Open source

DOI: 10.1007/s00210-019-01692-5
Published: 2019-08-02
Container: Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00210-019-01692-5,
  title = {RETRACTED ARTICLE: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism},
  author = {Nazila Fathi Maroufi and Vahid Vahedian and Seyed Ali Miresmaeili Mazrakhondi and Wesam Kooti and Hosein Ajami Khiavy and Roya Bazzaz and Fatemeh Ramezani and Seyed Mohammadbagher Pirouzpanah and Marjan Ghorbani and Maryam Akbarzadeh and Hamed Hajipour and Saeed Ghanbarzadeh and Mehdi Sabzichi},
  year = {2019},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-019-01692-5},
  url = {https://doi.org/10.1007/s00210-019-01692-5}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism
AU  - Nazila Fathi Maroufi
AU  - Vahid Vahedian
AU  - Seyed Ali Miresmaeili Mazrakhondi
AU  - Wesam Kooti
AU  - Hosein Ajami Khiavy
AU  - Roya Bazzaz
AU  - Fatemeh Ramezani
AU  - Seyed Mohammadbagher Pirouzpanah
AU  - Marjan Ghorbani
AU  - Maryam Akbarzadeh
AU  - Hamed Hajipour
AU  - Saeed Ghanbarzadeh
AU  - Mehdi Sabzichi
PY  - 2019
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-019-01692-5
UR  - https://doi.org/10.1007/s00210-019-01692-5
ER  -

APA

Maroufi, N. F., Vahedian, V., Mazrakhondi, S. A. M., Kooti, W., Khiavy, H. A., Bazzaz, R., Ramezani, F., Pirouzpanah, S. M., Ghorbani, M., Akbarzadeh, M., Hajipour, H., Ghanbarzadeh, S., & Sabzichi, M. (2019). RETRACTED ARTICLE: Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-019-01692-5

Source records

crossref · retrieved 2026-09-25T02:22:37.924Z